Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.4
edited by Sarantis Dimitriadis
on 2022/06/02 10:00
Change comment: There is no comment for this version
To version 10.1
edited by Sarantis Dimitriadis
on 2023/05/30 11:24
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -7,6 +7,8 @@
7 7  (% class="western" lang="en-GB" style="text-align:justify" %)
8 8  (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 9  
10 +:
11 +
10 10  * (((
11 11  (% lang="en-US" %)**Non-professional end users:**
12 12  
... ... @@ -15,6 +15,8 @@
15 15  * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
16 16  )))
17 17  
20 +:
21 +
18 18  * (((
19 19  (% lang="en-US" %)**Professional end users**
20 20  
... ... @@ -25,9 +25,13 @@
25 25  * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
26 26  )))
27 27  
32 +:
33 +
28 28  (% class="western" lang="en-GB" %)
29 29  (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
30 30  
37 +:
38 +
31 31  * (((
32 32  (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
33 33  
... ... @@ -42,6 +42,8 @@
42 42  * (% lang="en-US" %)Pharmaceutical companies
43 43  )))
44 44  
53 +:
54 +
45 45  * (((
46 46  (% lang="en-GB" %)
47 47  (% lang="en-US" %)**Public sector organizations:**
... ... @@ -57,6 +57,8 @@
57 57  * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
58 58  )))
59 59  
70 +:
71 +
60 60  * (((
61 61  (% lang="en-GB" %)
62 62  (% lang="en-US" %)**Education and research organizations:**
... ... @@ -70,6 +70,8 @@
70 70  * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
71 71  )))
72 72  
85 +:
86 +
73 73  * (((
74 74  (% lang="en-GB" %)
75 75  (% lang="en-US" %)**Civil society organizations:**
... ... @@ -77,6 +77,8 @@
77 77  * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
78 78  )))
79 79  
94 +:
95 +
80 80  * (((
81 81  (% lang="en-GB" %)
82 82  (% lang="en-US" %)**Networks and clusters:**
... ... @@ -85,276 +85,93 @@
85 85  * (% lang="en-US" %)International, national, regional and local networks
86 86  )))
87 87  
88 -(% class="western" lang="en-GB" %)
89 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
104 +:
90 90  
91 -
92 -(% cellspacing="0" class="table-striped" dir="ltr" style="margin-left:auto; margin-right:auto" %)
93 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:5px; padding:0in 0.08in; width:628px" %)(((
94 -(% class="western" lang="en-GB" style="text-align:center" %)
95 -(% lang="en-US" style="font-family:Calibri,serif" %)**Age or age group**
96 -)))
97 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
98 98  (% class="western" lang="en-GB" %)
99 -(% lang="en-US" style="font-family:Calibri,serif" %)Specific age range
100 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
101 -(% class="western" %)
107 +(% lang="en-US" %)Typical approaches to define (%%)//**non-professional **//end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table .
108 +
109 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
111 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
112 +(% lang="en-US" %)Specific age range
113 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
102 102  
103 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
115 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
104 104  (% class="western" %)
105 105  
106 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
107 107  (% class="western" %)
108 108  
109 109  )))
110 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
122 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)General Population
123 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
124 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
111 111  (% class="western" lang="en-GB" %)
112 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly
113 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
126 +(% lang="en-US" %)Healthy
127 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
114 114  (% class="western" lang="en-GB" %)
115 -(% lang="en-US" style="font-family:Calibri,serif" %)Adults
116 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
117 -(% class="western" lang="en-GB" %)
118 -(% lang="en-US" style="font-family:Calibri,serif" %)Youth
119 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
120 -(% class="western" lang="en-GB" %)
121 -(% lang="en-US" style="font-family:Calibri,serif" %)Children
122 -)))
123 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
124 -(% class="western" %)
125 125  
126 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
127 -(% class="western" %)
128 -
129 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
130 -(% class="western" %)
131 -
132 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
133 -(% class="western" %)
134 -
135 -)))
136 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
137 -(% class="western" lang="en-GB" style="text-align:center" %)
138 -(% lang="en-US" style="font-family:Calibri,serif" %)**Health status**
139 -)))
140 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
130 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
141 141  (% class="western" lang="en-GB" %)
142 -(% lang="en-US" style="font-family:Calibri,serif" %)Healthy
143 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
144 -(% class="western" lang="en-GB" %)
145 -(% lang="en-US" style="font-family:Calibri,serif" %)Patient
146 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
147 -(% class="western" lang="en-GB" %)
148 -(% lang="en-US" style="font-family:Calibri,serif" %)Rehabilitant
149 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
150 -(% class="western" lang="en-GB" %)
151 -(% lang="en-US" style="font-family:Calibri,serif" %)Recovered/Survivor
152 -)))
153 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
154 -(% class="western" %)
155 155  
156 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
157 -(% class="western" %)
158 -
159 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
160 -(% class="western" %)
161 -
162 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
163 -(% class="western" %)
164 -
165 -)))
166 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
167 -(% class="western" lang="en-GB" style="text-align:center" %)
168 -(% lang="en-US" style="font-family:Calibri,serif" %)**A specific disease, disorder or disability**
169 -)))
170 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
133 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
171 171  (% class="western" lang="en-GB" %)
172 -(% lang="en-US" style="font-family:Calibri,serif" %)ADHD
173 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
174 -(% class="western" lang="en-GB" %)
175 -(% lang="en-US" style="font-family:Calibri,serif" %)Dementia
176 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
177 -(% class="western" lang="en-GB" %)
178 -(% lang="en-US" style="font-family:Calibri,serif" %)Parkinsons’ disease
179 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
180 -(% class="western" lang="en-GB" %)
181 -(% lang="en-US" style="font-family:Calibri,serif" %)Loneliness and Social Isolation
182 -)))
183 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
184 -(% class="western" lang="en-GB" %)
185 -(% lang="en-US" style="font-family:Calibri,serif" %)Autism
186 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
187 -(% class="western" lang="en-GB" %)
188 -(% lang="en-US" style="font-family:Calibri,serif" %)Down syndrome
189 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
190 -(% class="western" lang="en-GB" %)
191 -(% lang="en-US" style="font-family:Calibri,serif" %)Physical disability
192 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
193 -(% class="western" lang="en-GB" %)
194 -(% lang="en-US" style="font-family:Calibri,serif" %)Mental health
195 -)))
196 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
197 -(% class="western" lang="en-GB" %)
198 -(% lang="en-US" style="font-family:Calibri,serif" %)Cardiovascular disease
199 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
200 -(% class="western" lang="en-GB" %)
201 -(% lang="en-US" style="font-family:Calibri,serif" %)Idiopathic pulmonary fibrosis (IPF)
202 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
203 -(% class="western" lang="en-GB" %)
204 -(% lang="en-US" style="font-family:Calibri,serif" %)Sleep apnea/apnea
205 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
206 -(% class="western" lang="en-GB" %)
207 -(% lang="en-US" style="font-family:Calibri,serif" %)Mild cognitive impairment
208 -)))
209 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
210 -(% class="western" lang="en-GB" %)
211 -(% lang="en-US" style="font-family:Calibri,serif" %)Chronic Obstructive Pulmonary Disease (COPD)
212 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
213 -(% class="western" lang="en-GB" %)
214 -(% lang="en-US" style="font-family:Calibri,serif" %)Language disability
215 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
216 -(% class="western" lang="en-GB" %)
217 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance abuse (drugs, alcohol)
218 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
219 -(% class="western" lang="en-GB" %)
220 -(% lang="en-US" style="font-family:Calibri,serif" %)Multiple sclerosis
221 -)))
222 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
223 -(% class="western" lang="en-GB" %)
224 -(% lang="en-US" style="font-family:Calibri,serif" %)Cognitive disorder (mild, major)
225 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
226 -(% class="western" lang="en-GB" %)
227 -(% lang="en-US" style="font-family:Calibri,serif" %)Intellectual disability/ Learning difficulty/ Mental retardation
228 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
229 -(% class="western" lang="en-GB" %)
230 -(% lang="en-US" style="font-family:Calibri,serif" %)Trauma patient
231 -
232 -(% class="western" lang="en-GB" %)
233 -(% lang="en-US" style="font-family:Calibri,serif" %)(e.g., a spinal cord injury)
234 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
235 -(% class="western" lang="en-GB" %)
236 -(% lang="en-US" style="font-family:Calibri,serif" %)Neurodegenerative diseases
237 -)))
238 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
239 -(% class="western" %)
240 240  
241 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
242 -(% class="western" %)
243 -
244 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
245 -(% class="western" %)
246 -
247 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
248 -(% class="western" %)
249 -
250 250  )))
251 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
252 -(% class="western" lang="en-GB" style="text-align:center" %)
253 -(% lang="en-US" style="font-family:Calibri,serif" %)**Clients of a specific service**
254 -)))
255 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
137 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
138 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Schizophrenia|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease
139 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Post-Stroke Patients with Moving or Linguistic Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Sleep Disorders: e.g., Apnea, Hypopnea|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
140 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
141 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
142 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
143 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
256 256  (% class="western" lang="en-GB" %)
257 -(% lang="en-US" style="font-family:Calibri,serif" %)Child welfare
258 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
259 -(% class="western" lang="en-GB" %)
260 -(% lang="en-US" style="font-family:Calibri,serif" %)Nursing home
261 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
262 -(% class="western" lang="en-GB" %)
263 -(% lang="en-US" style="font-family:Calibri,serif" %)Employment service
264 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
265 -(% class="western" %)
266 266  
267 -)))
268 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
146 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
269 269  (% class="western" lang="en-GB" %)
270 -(% lang="en-US" style="font-family:Calibri,serif" %)Early childhood education
271 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
272 -(% class="western" lang="en-GB" %)
273 -(% lang="en-US" style="font-family:Calibri,serif" %)Home care
274 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
275 -(% class="western" lang="en-GB" %)
276 276  
277 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
149 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
278 278  (% class="western" lang="en-GB" %)
279 279  
280 280  )))
281 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
282 -(% class="western" %)
283 -
284 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
285 -(% class="western" %)
286 -
287 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
288 -(% class="western" %)
289 -
290 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
291 -(% class="western" %)
292 -
293 -)))
294 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
295 -(% class="western" lang="en-GB" style="text-align:center" %)
296 -(% lang="en-US" style="font-family:Calibri,serif" %)**Vulnerable groups**
297 -)))
298 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
153 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
154 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="text-align:justify; vertical-align:middle" %)Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
299 299  (% class="western" lang="en-GB" %)
300 -(% lang="en-US" style="font-family:Calibri,serif" %)Minors/Children
301 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
302 -(% class="western" lang="en-GB" %)
303 -(% lang="en-US" style="font-family:Calibri,serif" %)Single parents with minor children
304 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
305 -(% class="western" lang="en-GB" %)
306 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons subjected to psychological, physical or sexual violence
307 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
308 -(% class="western" lang="en-GB" %)
309 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance users
310 -
311 -(% class="western" lang="en-GB" %)
312 -(% lang="en-US" style="font-family:Calibri,serif" %)(drugs, alcohol)
156 +Down Syndrome
313 313  )))
314 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
158 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
315 315  (% class="western" lang="en-GB" %)
316 -(% lang="en-US" style="font-family:Calibri,serif" %)Disabled people
317 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
318 -(% class="western" lang="en-GB" %)
319 -(% lang="en-US" style="font-family:Calibri,serif" %)Victims of trafficking in human beings
320 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
321 -(% class="western" lang="en-GB" %)
322 -(% lang="en-US" style="font-family:Calibri,serif" %)Ethnic minorities and immigrants
323 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
324 -(% class="western" lang="en-GB" %)
325 -(% lang="en-US" style="font-family:Calibri,serif" %)Isolated people
160 +
326 326  )))
327 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
328 -(% class="western" lang="en-GB" %)
329 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly people
330 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
331 -(% class="western" lang="en-GB" %)
332 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with serious illnesses
333 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
334 -(% class="western" lang="en-GB" %)
335 -(% lang="en-US" style="font-family:Calibri,serif" %)Homeless people
336 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
337 -(% class="western" lang="en-GB" %)
338 -(% lang="en-US" style="font-family:Calibri,serif" %)Ex-prisoners and people with criminal background
339 -)))
340 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
341 -(% class="western" lang="en-GB" %)
342 -(% lang="en-US" style="font-family:Calibri,serif" %)Pregnant women
343 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
344 -(% class="western" lang="en-GB" %)
345 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with mental disorders
346 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
347 -(% class="western" lang="en-GB" %)
162 +
163 +
164 +:
165 +:
166 +: (% lang="en-US" %)Typical approaches to define (%%)//**professional **//end users in health and wellbeing living lab projects are presented in the following table .
167 +
168 +(((
169 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
170 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Informal Caregivers**
171 +|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)Part of adults and citizens' group|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)
172 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Health Care Professionals / Formal Caregivers**
173 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Doctors|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Social workers|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapists|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Psychologists
174 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Registered nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Practical nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Physicians|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
175 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Students**
176 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Medical|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Engineering|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Computer Science|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Pedagogues
177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)English Literature|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Nursing|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapy|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Social Services
178 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Health Care Management|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
179 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Organizations**
180 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Hospitals|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Nursing homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Care homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Home care Organizations
181 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Network organizations|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Day care centers|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)
182 +
348 348  
349 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
350 -(% class="western" lang="en-GB" %)
351 -
352 352  )))
353 353  
186 +:
187 +
354 354  (% class="western" lang="en-GB" %)
355 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
189 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
356 356  
357 -
358 358  |**Researcher expertise**|**Brief use case description**
359 359  |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making
360 360  |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project